Health
Pharmaceutical trade group sues Biden administration over Medicare drug price negotiations
Traders work on the floor of the New York Stock Exchange during morning trading, April 10, 2023. Michael M. Santiago | Getty Images The pharmaceutical industry’s largest lobbying group and two other organizations on Wednesday sued the Biden Administration over Medicare’s new powers to slash drug prices for seniors under the Inflation Reduction Act. Pharmaceutical […]
Read More
‘You’re not God’: Doctors and patient families say HCA hospitals push hospice care
Alma Salas and her daughter, Marisol Perez. Courtesy: Alma Salas As Marisol Perez fought for her life in a Texas hospital in autumn 2021, her mother, Alma Salas, sat with her every day praying. Perez, then 42, had such a virulent case of Covid and pneumonia that doctors at St. David’s North Austin Medical Center, […]
Read More
CEOs do matter when picking stocks. 5 things we look for in a leader and examples from our portfolio
It’s not unusual for a company’s stock price to soar — or sink — on news of a CEO shakeup. When Mary Dillon, revered on Wall Street for her eight-year run at Ulta Beauty (ULTA), was named to the top job at Foot Locker (FL) last year, the shoe retailer’s stock jumped 20% in a […]
Read More
Novo Nordisk sues clinics allegedly selling knockoff versions of Ozempic and Wegovy
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, California. Mario Tama | Getty Images Novo Nordisk on Tuesday sued five medical spas and wellness clinics for allegedly selling cheaper, unauthorized versions of the company’s weight loss drugs Ozempic and Wegovy. The […]
Read More
These 3 stocks are troubled but I’m not ready to give up
If you were to tell me that Club names Estee Lauder (EL) or Danaher (DHR) would ever miss their quarters not once but twice, I would have told you to go get your head examined. These are clockwork beat and raise companies, which is why it’s so hard to value them now. Johnson & Johnson […]
Read More
Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push
David Ricks, CEO, Eli Lilly Scott Mlyn | CNBC Eli Lilly on Tuesday said it struck a $2.4 billion deal to acquire Dice Therapeutics in a bid to bulk up its treatment portfolio for immune-related diseases. Eli Lilly will pay $48 per share in cash to buy Dice, representing around a 40% premium to where […]
Read More
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
Chief Executive Officers of pharmaceutical companies testify before the Senate Finance Committee on “Drug Pricing in America: A Prescription for Change, Part II” February 26, 2019 in Washington, DC. From left to right are Richard A. Gonzalez, chairman and CEO of AbbVie Inc; Pascal Soriot, executive director and CEO of AstraZeneca; Giovanni Caforio, chairman of […]
Read More
These medical device makers are driving a ‘paradigm’ shift in cardiac care, Piper Sandler says
A safer, quicker way to treat some heart arrhythmia cases could be on the horizon, creating an opportunity for medical device companies Boston Scientific and Medtronic, according to Piper Sandler analyst Matt O’Brien. Atrial fibrillation (AF) is the most common type of heart arrhythmia, according to the Centers for Disease Control and Prevention. It estimates […]
Read More
Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit
Bristol Myers Squibb on Friday sued the Biden administration over Medicare’s new powers to slash drug prices, the third such lawsuit to be filed against the program in a matter of days. The lawsuit, filed in federal district court in New Jersey, argues the Medicare negotiations violate the First and Fifth Amendments of the U.S. […]
Read More
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall
XBB.1.5 strain of Covid CFOTO | Future Publishing | Getty Images The U.S. Food and Drug Administration on Friday recommended that vaccine manufacturers make single-strain Covid shots for the fall that target omicron subvariant XBB.1.5, the dominant strain of the virus nationwide. “Based on the totality of the evidence, FDA has advised manufacturers who will […]
Read More